{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T21:04:31Z","timestamp":1786741471723,"version":"build-2736575974"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.coi.2023.102370","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T14:01:54Z","timestamp":1690293714000},"page":"102370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Viral-vectored respiratory mucosal vaccine strategies"],"prefix":"10.1016","volume":"84","author":[{"given":"Mangalakumari","family":"Jeyanathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Afkhami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2023.102370_bib1","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S1473-3099(22)00445-5","article-title":"Trends in the global burden of lower respiratory infections: the knowns and the unknowns","volume":"22","author":"Li","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2023.102370_bib2","unstructured":"WHO: WHO coronavirus (COVID-19) dashboard. 2023. \u3008https:\/\/covid19.who.int\u3009."},{"key":"10.1016\/j.coi.2023.102370_bib3","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1093\/infdis\/jiy728","article-title":"Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic","volume":"219","author":"Morens","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2023.102370_bib4","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3389\/fimmu.2020.01507","article-title":"Current Insights in the Development of Efficacious Vaccines Against RSV","volume":"11","author":"Soto","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib5","unstructured":"WHO: Registry data of COVID-19 vaccine candidates. 2023. \u3008https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines\u3009."},{"key":"10.1016\/j.coi.2023.102370_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/d41586-021-00241-6","article-title":"How to redesign COVID vaccines so they protect against variants","volume":"590","author":"Callaway","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.coi.2023.102370_bib7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41577-021-00556-5","article-title":"Will SARS-CoV-2 variants of concern affect the promise of vaccines?","volume":"21","author":"Gupta","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41577-020-00434-6","article-title":"Immunological considerations for COVID-19 vaccine strategies","volume":"20","author":"Jeyanathan","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib9","doi-asserted-by":"crossref","first-page":"S405","DOI":"10.1093\/infdis\/jiab269","article-title":"Influenza vaccines: successes and continuing challenges","volume":"224","author":"Becker","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2023.102370_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/v13020199","article-title":"Immunity against influenza: the long way from animal models towards a real-life universal flu vaccine","volume":"13","author":"Schmidt","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.coi.2023.102370_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1126\/science.add2897","article-title":"T cell immunity to COVID-19 vaccines","volume":"377","author":"Wherry","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.coi.2023.102370_bib12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/JLB.4MR0220-446R","article-title":"Innate immune memory of tissue-resident macrophages and trained innate immunity: re-vamping vaccine concept and strategies","volume":"108","author":"Xing","year":"2020","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.coi.2023.102370_bib13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1146\/annurev-immunol-102119-073855","article-title":"Trained Immunity: reprogramming innate immunity in health and disease","volume":"39","author":"Bekkering","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines - fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2023.102370_sbref14","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","article-title":"Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2","volume":"185","author":"Afkhami","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.coi.2023.102370_sbref15","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.cell.2018.09.042","article-title":"Induction of autonomous memory alveolar macrophages requires T cell help and is critical to trained immunity","volume":"175","author":"Yao","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.coi.2023.102370_sbref16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.155655","article-title":"Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans","volume":"7","author":"Jeyanathan","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.coi.2023.102370_othref0015","unstructured":"Singh C., Verma S., Reddy P., Diamond M.S., Curiel D.T., Patel C., Jain M.K., Redkar S.V., Bhate A.S., Gundappa V., et al.: Immunogenicity and tolerability of BBV154 (iNCOVACC\u00ae), an intranasal SARS-CoV-2 vaccine, compared with intramuscular Covaxin\u00ae in healthy adults: a randomised, open-label, phase 3 clinical trial. doi.org\/102139\/ssrn4342771"},{"key":"10.1016\/j.coi.2023.102370_bib20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(14)70845-X","article-title":"Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial","volume":"14","author":"Satti","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2023.102370_bib21","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.4049\/jimmunol.2000532","article-title":"Airway macrophages mediate mucosal vaccine-induced trained innate immunity against Mycobacterium tuberculosis in early stages of infection","volume":"205","author":"D\u2019Agostino","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.30","article-title":"Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens","volume":"3","author":"Afkhami","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.coi.2023.102370_sbref20","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.vaccine.2016.12.008","article-title":"Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques","volume":"35","author":"Bolton","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2023.102370_bib24","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1128\/JVI.02563-09","article-title":"Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes","volume":"84","author":"Kaufman","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2023.102370_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.coi.2011.03.006","article-title":"Viral vectors as vaccine platforms: deployment in sight","volume":"23","author":"Rollier","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003548","article-title":"Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice","volume":"3","author":"Croyle","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2023.102370_sbref24","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S1473-3099(21)00396-0","article-title":"Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial","volume":"21","author":"Wu","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2023.102370_bib28","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.4049\/jimmunol.1100302","article-title":"CD8+ T effector memory cells protect against liver-stage malaria","volume":"187","author":"Reyes-Sandoval","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1186\/s12864-021-08061-8","article-title":"Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen","volume":"22","author":"Sheerin","year":"2021","journal-title":"BMC Genom"},{"key":"10.1016\/j.coi.2023.102370_bib30","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI78280","article-title":"Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling","volume":"125","author":"Quinn","year":"2015","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coi.2023.102370_bib31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.mt.6300024","article-title":"Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector","volume":"15","author":"Hensley","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.coi.2023.102370_bib32","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/mi.2012.103","article-title":"Differentially imprinted innate immunity by mucosal boost vaccination determines antituberculosis immune protective outcomes, independent of T-cell immunity","volume":"6","author":"Jeyanathan","year":"2013","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib33","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/mi.2015.29","article-title":"Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection","volume":"8","author":"Jeyanathan","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2023.102370_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104298","article-title":"Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: an open-label partially-randomised ascending dose phase I trial","volume":"85","author":"Madhavan","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coi.2023.102370_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002790","article-title":"Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: a phase I randomised controlled trial","volume":"16","author":"Manjaly Thomas","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.coi.2023.102370_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103841","article-title":"Intranasal COVID-19 vaccines: from bench to bed","volume":"76","author":"Alu","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coi.2023.102370_bib38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.chom.2022.11.016","article-title":"Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses","volume":"31","author":"Morens","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2023.102370_bib39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.it.2018.01.006","article-title":"New tuberculosis vaccine strategies: taking aim at un-natural immunity","volume":"39","author":"Jeyanathan","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib40","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S2213-2600(22)00131-X","article-title":"Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials","volume":"10","author":"Zhu","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.coi.2023.102370_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2023.102370_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.vaccine.2012.10.084","article-title":"Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials","volume":"31","author":"DiazGranados","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2023.102370_bib43","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.scib.2022.05.018","article-title":"A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2","volume":"67","author":"Chen","year":"2022","journal-title":"Sci Bull"},{"key":"10.1016\/j.coi.2023.102370_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.abh0755","article-title":"Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models","volume":"13","author":"Van Doremalen","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2023.102370_bib45","article-title":"Lung tissue-resident memory T cells: the gatekeeper to respiratory viral (re)-infection","volume":"80","author":"Tang","year":"2022","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.it.2010.05.002","article-title":"Airway luminal T cells: a newcomer on the stage of TB vaccination strategies","volume":"31","author":"Jeyanathan","year":"2010","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib47","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1183\/16000617.00002515","article-title":"Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments","volume":"24","author":"Lai","year":"2015","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.coi.2023.102370_bib48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nri.2015.16","article-title":"T cell migration, search strategies and mechanisms","volume":"16","author":"Krummel","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib49","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1084\/jem.20130091","article-title":"Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4","volume":"210","author":"Mikhak","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2023.102370_bib50","article-title":"The rate of CD4 T cell entry into the lungs during Mycobacterium tuberculosis infection is determined by partial and opposing effects of multiple chemokine receptors","volume":"87","author":"Hoft","year":"2019","journal-title":"Infect Immun"},{"key":"10.1016\/j.coi.2023.102370_bib51","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.4049\/jimmunol.1700382","article-title":"CXCR3 signaling is required for restricted homing of parenteral tuberculosis vaccine-induced T cells to both the lung parenchyma and airway","volume":"199","author":"Jeyanathan","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib52","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1084\/jem.20181308","article-title":"CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways","volume":"216","author":"Wein","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2023.102370_bib53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1165\/rcmb.2010-0241OC","article-title":"The \u03b14\u03b21 integrin in localization of Mycobacterium tuberculosis-specific T helper type 1 cells to the human lung","volume":"45","author":"Walrath","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.coi.2023.102370_bib54","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41385-021-00461-z","article-title":"Tissue resident memory T cells in the respiratory tract","volume":"15","author":"Zheng","year":"2022","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.coi.2023.102370_sbref52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41385-020-0309-3","article-title":"Long-term maintenance of lung resident memory T cells is mediated by persistent antigen","volume":"14","author":"Uddb\u00e4ck","year":"2021","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib56","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1164\/rccm.200910-1583OC","article-title":"Murine airway luminal antituberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment","volume":"181","author":"Jeyanathan","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2023.102370_bib57","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41590-019-0584-x","article-title":"Environmental cues regulate epigenetic reprogramming of airway-resident memory CD8+ T cells","volume":"21","author":"Hayward","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aag2031","article-title":"Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity","volume":"2","author":"Sl\u00fctter","year":"2017","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aav5581","article-title":"Generation and persistence of human tissue-resident memory T cells in lung transplantation","volume":"4","author":"Snyder","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib60","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/imr.12649","article-title":"Memory CD8 T cell inflation vs tissue-resident memory T cells: same patrollers, same controllers?","volume":"283","author":"Welten","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2023.102370_bib61","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.4049\/jimmunol.1202665","article-title":"A new model for CD8+ T cell memory inflation based upon a recombinant adenoviral vector","volume":"190","author":"Bolinger","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib62","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41590-021-00969-3","article-title":"Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8+ T cells","volume":"22","author":"Cupovic","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib63","article-title":"Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections","volume":"3","author":"Chandran","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.coi.2023.102370_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2023.102370_sbref62","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41590-022-01354-4","article-title":"Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut-lung axis","volume":"23","author":"Jeyanathan","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib66","doi-asserted-by":"crossref","first-page":"8220","DOI":"10.1128\/JVI.72.10.8220-8229.1998","article-title":"Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions","volume":"72","author":"Balmelli","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2023.102370_bib67","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41541-017-0022-8","article-title":"Needle-free delivery of measles virus vaccine to the lower respiratory tract of non-human primates elicits optimal immunity and protection","volume":"2","author":"de Swart","year":"2017","journal-title":"NPJ Vaccin"},{"key":"10.1016\/j.coi.2023.102370_bib68","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2567.2007.02641.x","article-title":"The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response","volume":"122","author":"Minne","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.coi.2023.102370_bib69","doi-asserted-by":"crossref","first-page":"22213","DOI":"10.1073\/pnas.1015536108","article-title":"Genetic immunization in the lung induces potent local and systemic immune responses","volume":"107","author":"Song","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2023.102370_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.860399","article-title":"Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes","volume":"13","author":"Jeyanathan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2023.102370_bib71","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.immuni.2022.04.013","article-title":"Mucosal immune responses to infection and vaccination in the respiratory tract","volume":"55","author":"Mettelman","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2023.102370_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics11080375","article-title":"Mucosal vaccination via the respiratory tract","volume":"11","author":"Hellfritzsch","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.coi.2023.102370_bib73","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1407417","article-title":"A randomized, controlled trial of an aerosolized vaccine against measles","volume":"372","author":"Low","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2023.102370_bib74","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-2600(22)00087-X","article-title":"Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial","volume":"10","author":"Li","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.coi.2023.102370_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70325-2","article-title":"Spray dried VSV-vectored vaccine is thermally stable and immunologically active in vivo","volume":"10","author":"Toniolo","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2023.102370_bib76","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination","volume":"384","author":"Muir","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2023.102370_bib77","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMc2210813","article-title":"Vaccine-induced immune thrombocytopenia and thrombosis after the Sputnik V vaccine","volume":"387","author":"Herrera-Comoglio","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2023.102370_bib78","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood.2022017696","article-title":"Vaccine-induced immune thrombotic thrombocytopenia","volume":"141","author":"Cines","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.coi.2023.102370_bib79","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood.2021014712","article-title":"Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration","volume":"140","author":"Nicolai","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.coi.2023.102370_bib80","doi-asserted-by":"crossref","first-page":"8213","DOI":"10.1126\/sciadv.abl8213","article-title":"ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome","volume":"7","author":"Baker","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.coi.2023.102370_bib81","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1182\/blood.2022016474","article-title":"Vaccine-induced immune thrombotic thrombocytopenia is mediated by a stereotyped clonotypic antibody","volume":"140","author":"Wang","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.coi.2023.102370_bib82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41541-023-00662-6","article-title":"Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico","volume":"8","author":"Ponce-de-Le\u00f3n","year":"2023","journal-title":"NPJ Vaccin"},{"key":"10.1016\/j.coi.2023.102370_bib83","volume":"5","author":"Green","year":"2015","journal-title":"BMJ Open"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791523000894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791523000894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:49:24Z","timestamp":1760604564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791523000894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":83,"alternative-id":["S0952791523000894"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2023.102370","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral-vectored respiratory mucosal vaccine strategies","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2023.102370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102370"}}